Communiqués de presse de Palamina

Investigational dissolving microneedle platform uses the therapeutic peptide as the structural material of the needle itself, with an initial focus on sports medicine and regenerative medicine TORONTO…

Jackson to lead organic and inorganic growth initiatives, strategic partnerships and corporate development as the Company advances its life sciences and therapeutics platforms TORONTO, Oct. 19, 2026 /…

Vancouver, British Columbia--(Newsfile Corp. - October 15, 2026) - Pacific Arc Resources Ltd. (TSXV: PAV.H) (the "Company") announces that Stephen Brohman has resigned as Chief Financial Officer of th…

Capital markets executive and long-time Company stakeholder joins senior leadership to help drive Vector's next phase of growth TORONTO, Oct. 14, 2026 /PRNewswire/ -- Vector Science & Therapeutics Cor…

Investment advances collaboration on peptide-based products for women's wellness MEQUON, Wis., Oct. 13, 2026 /PRNewswire/ -- Vector Science and Therapeutics Corp. (TSXV: PAIN) ("Vector" or the "Compan…

Investment advances collaboration on peptide-based products for athletic performance, recovery and longevity TORONTO, Oct. 7, 2026 /PRNewswire/ -- Vector Science and Therapeutics Corp. (TSXV: PAIN) ("…

Toronto, Ontario--(Newsfile Corp. - September 29, 2026) - Palamina Corp. (TSXV: PA) (OTCQB: PLMNF) ("Palamina" or the "Company") confirms that it has closed the previously announced plan of arrangemen…

Mequon, Wisconsin--(Newsfile Corp. - September 25, 2026) - Vector Science and Therapeutics Corp. (TSXV: PAIN) ("Vector" or the "Company") today announced that the Board of Directors has approved the g…

Toronto, Ontario--(Newsfile Corp. - September 25, 2026) - Palamina Corp. (TSXV: PA) (OTCQB: PLMNF) ("Palamina" or the "Company") is pleased to announce that the previously announced spin-out transacti…

Toronto, Ontario--(Newsfile Corp. - September 1, 2026) - Palamina Corp. (TSXV: PA) (OTCQB: PLMNF) has mailed its management information circular (the "Circular") and related proxy materials to its sha…

Toronto, Ontario--(Newsfile Corp. - August 31, 2026) - Paragon Advanced Labs Inc. (TSXV: PALS) ("Paragon" or the "Company"), a provider of advanced mineral analytical services to the natural resource…

Toronto, Ontario--(Newsfile Corp. - August 28, 2026) - Palamina Corp. (TSXV: PA) (OTCQB: PLMNF) holds a 100% interest in its Canadian subsidiary, Colt Silver Corp. ("Colt") which through its Peruvian…

Toronto, Ontario--(Newsfile Corp. - August 26, 2026) - Paragon Advanced Labs Inc. (TSXV: PALS) ("Paragon" or the "Company"), a provider of advanced analytical technologies to the global mining industr…

MEQUON, Wis., Aug. 25, 2026 /PRNewswire/ -- Vector Science and Therapeutics Corp. (TSXV: PAIN) ("Vector" or the "Company") is pleased to announce that the Company has entered into an investor relation…

55,000 vials of peptides will be produced from this production suite and are pre-sold Milestone facility meets cGMP, FDA, and ISO quality standards on schedule; remaining three suites to launch in Sep…

Platform combines regenerative peptides with autologous platelet-rich biologics, alongside adjunct formulations designed to avoid interfering with the body's own repair cells MEQUON, Wis., Aug. 20, 20…

Long-term agreement secures U.S.-based, cGMP manufacturing capacity for Vector's proprietary peptide platform, with quality testing performed by its affiliate Verlytix MEQUON, Wis., Aug. 17, 2026 /PRN…